Dextran-based biodegradable nanoparticles: an alternative and convenient strategy for treatment of traumatic spinal cord injury

Wei Liu,1,* Peng Quan,2,* Qingqing Li,1,* Pengyu Tang,1 Jian Chen,1 Tao Jiang,3 Weihua Cai1 1Department of Orthopaedics, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu 210029, China; 2Department of Pharmaceutical Science, School of Pharmacy, Shenyang Pharmaceutical Un...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Liu W, Quan P, Li Q, Tang P, Chen J, Jiang T, Cai W
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2018
Materias:
Acceso en línea:https://doaj.org/article/6b65d833d34d41689d95c61347c15925
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:6b65d833d34d41689d95c61347c15925
record_format dspace
spelling oai:doaj.org-article:6b65d833d34d41689d95c61347c159252021-12-02T00:20:35ZDextran-based biodegradable nanoparticles: an alternative and convenient strategy for treatment of traumatic spinal cord injury1178-2013https://doaj.org/article/6b65d833d34d41689d95c61347c159252018-07-01T00:00:00Zhttps://www.dovepress.com/dextran-based-biodegradable-nanoparticles-an-alternative-and-convenien-peer-reviewed-article-IJNhttps://doaj.org/toc/1178-2013Wei Liu,1,* Peng Quan,2,* Qingqing Li,1,* Pengyu Tang,1 Jian Chen,1 Tao Jiang,3 Weihua Cai1 1Department of Orthopaedics, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu 210029, China; 2Department of Pharmaceutical Science, School of Pharmacy, Shenyang Pharmaceutical University, Shenyang, China; 3Department of Orthopaedics, Wuxi People’s Hospital Affiliated to Nanjing Medical University, Wuxi, Jiangsu 214023, China *These authors contributed equally to this work Introduction: After traumatic spinal cord injury (SCI), an inhibitory environment that contains chondroitin sulfate proteoglycans (CSPGs) is formed that prevents axonal regeneration and growth.Materials and methods: As previously reported, local administration of Taxol® at a low concentration has shown promising abilities to promote axonal regeneration and downregulate inhibitory molecules after acute SCI. However, the application of an invasive miniosmotic pump to deliver Taxol and the Cremophor-related toxicity caused by Taxol limits the administration of Taxol.Results: In this study, the sustained release of paclitaxel (PTX) for 7 days was achieved by incorporating PTX into acetalated dextran (Ac-DEX) nanoparticles, and the prepared PTX-loaded Ac-DEX (PTX@Ac-DEX) nanoparticles promoted neurite extension in the presence of CSPGs. In a rat SCI model, both PTX@Ac-DEX and Taxol enhanced neural regeneration, inhibited CSPGs, protected the injured spinal cord, and improved locomotor recovery. Because of the sustained release of PTX, single administration of PTX@Ac-DEX showed equal therapeutic effect with Taxol, which need to be administered for seven days using a surgically implanted miniosmotic pump.Conclusion: Overall, this study provides an effective and convenient strategy for SCI therapy, which can improve neurite extension across an inhibitory environment and avoid Cremophor-related toxicity caused by Taxol. Keywords: acetalated dextran, nanoparticle, paclitaxel, spinal cord injuryLiu WQuan PLi QTang PChen JJiang TCai WDove Medical Pressarticleacetalated dextrannanoparticlepaclitaxelspinal cord injuryMedicine (General)R5-920ENInternational Journal of Nanomedicine, Vol Volume 13, Pp 4121-4132 (2018)
institution DOAJ
collection DOAJ
language EN
topic acetalated dextran
nanoparticle
paclitaxel
spinal cord injury
Medicine (General)
R5-920
spellingShingle acetalated dextran
nanoparticle
paclitaxel
spinal cord injury
Medicine (General)
R5-920
Liu W
Quan P
Li Q
Tang P
Chen J
Jiang T
Cai W
Dextran-based biodegradable nanoparticles: an alternative and convenient strategy for treatment of traumatic spinal cord injury
description Wei Liu,1,* Peng Quan,2,* Qingqing Li,1,* Pengyu Tang,1 Jian Chen,1 Tao Jiang,3 Weihua Cai1 1Department of Orthopaedics, The First Affiliated Hospital of Nanjing Medical University, Nanjing, Jiangsu 210029, China; 2Department of Pharmaceutical Science, School of Pharmacy, Shenyang Pharmaceutical University, Shenyang, China; 3Department of Orthopaedics, Wuxi People’s Hospital Affiliated to Nanjing Medical University, Wuxi, Jiangsu 214023, China *These authors contributed equally to this work Introduction: After traumatic spinal cord injury (SCI), an inhibitory environment that contains chondroitin sulfate proteoglycans (CSPGs) is formed that prevents axonal regeneration and growth.Materials and methods: As previously reported, local administration of Taxol® at a low concentration has shown promising abilities to promote axonal regeneration and downregulate inhibitory molecules after acute SCI. However, the application of an invasive miniosmotic pump to deliver Taxol and the Cremophor-related toxicity caused by Taxol limits the administration of Taxol.Results: In this study, the sustained release of paclitaxel (PTX) for 7 days was achieved by incorporating PTX into acetalated dextran (Ac-DEX) nanoparticles, and the prepared PTX-loaded Ac-DEX (PTX@Ac-DEX) nanoparticles promoted neurite extension in the presence of CSPGs. In a rat SCI model, both PTX@Ac-DEX and Taxol enhanced neural regeneration, inhibited CSPGs, protected the injured spinal cord, and improved locomotor recovery. Because of the sustained release of PTX, single administration of PTX@Ac-DEX showed equal therapeutic effect with Taxol, which need to be administered for seven days using a surgically implanted miniosmotic pump.Conclusion: Overall, this study provides an effective and convenient strategy for SCI therapy, which can improve neurite extension across an inhibitory environment and avoid Cremophor-related toxicity caused by Taxol. Keywords: acetalated dextran, nanoparticle, paclitaxel, spinal cord injury
format article
author Liu W
Quan P
Li Q
Tang P
Chen J
Jiang T
Cai W
author_facet Liu W
Quan P
Li Q
Tang P
Chen J
Jiang T
Cai W
author_sort Liu W
title Dextran-based biodegradable nanoparticles: an alternative and convenient strategy for treatment of traumatic spinal cord injury
title_short Dextran-based biodegradable nanoparticles: an alternative and convenient strategy for treatment of traumatic spinal cord injury
title_full Dextran-based biodegradable nanoparticles: an alternative and convenient strategy for treatment of traumatic spinal cord injury
title_fullStr Dextran-based biodegradable nanoparticles: an alternative and convenient strategy for treatment of traumatic spinal cord injury
title_full_unstemmed Dextran-based biodegradable nanoparticles: an alternative and convenient strategy for treatment of traumatic spinal cord injury
title_sort dextran-based biodegradable nanoparticles: an alternative and convenient strategy for treatment of traumatic spinal cord injury
publisher Dove Medical Press
publishDate 2018
url https://doaj.org/article/6b65d833d34d41689d95c61347c15925
work_keys_str_mv AT liuw dextranbasedbiodegradablenanoparticlesanalternativeandconvenientstrategyfortreatmentoftraumaticspinalcordinjury
AT quanp dextranbasedbiodegradablenanoparticlesanalternativeandconvenientstrategyfortreatmentoftraumaticspinalcordinjury
AT liq dextranbasedbiodegradablenanoparticlesanalternativeandconvenientstrategyfortreatmentoftraumaticspinalcordinjury
AT tangp dextranbasedbiodegradablenanoparticlesanalternativeandconvenientstrategyfortreatmentoftraumaticspinalcordinjury
AT chenj dextranbasedbiodegradablenanoparticlesanalternativeandconvenientstrategyfortreatmentoftraumaticspinalcordinjury
AT jiangt dextranbasedbiodegradablenanoparticlesanalternativeandconvenientstrategyfortreatmentoftraumaticspinalcordinjury
AT caiw dextranbasedbiodegradablenanoparticlesanalternativeandconvenientstrategyfortreatmentoftraumaticspinalcordinjury
_version_ 1718403805755736064